Direktori | Umum | Sistem QUEST3+ 

Banner NPRA

               
Product Search   QUEST3+ System   Enquiries   Sitemap  

New Publication: Reaksi Drug Safety News - Issue 4/2017

Jumlah paparan: 18629

Kadar pengguna: 1 / 5

bintang aktifBintang tidak aktifBintang tidak aktifBintang tidak aktifBintang tidak aktif
 

REAKSI Drug Safety News,

Issue 4/2017, Vol. 36

 

  • Hyoscine Butylbromide Injection: Risk of Serious Adverse Effects in Patients with Underlying Cardiac Disease
  • Keytruda® (pembrolizumab): Risk of Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN)

 



 		  
  DOWNLOAD PDF

 

 

 

Rating:
( 1 Rating )

 

National Pharmaceutical Regulatory Agency (NPRA)

Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.

  • Phone: +603-7883 5400

 

 

More Links

Our Location

Public Enquiry

Privacy & Policy

Archives

More Links

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

NPRA Product StatusNPRA Product Status

NPRA Product Status

Site Last Modified

  • Last Modified: Khamis 31 Oktober 2024, 08:00:16.

Online Services

© Copyright 2018 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA

Search

Choose Your Language

Menu Utama